8-K current report · filed Oct 28, 2026

Encompass Health Corp (EHC) 8-K Current Report: October 28, 2026

Item EX-99.1Item EX-99.2Item 7.01Item 2.02EHC overview

Short answer

Encompass Health Corp (EHC) filed an 8-K current report with the SEC on October 28, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2), Item 7.01 (Regulation FD Disclosure), Item 2.02 (Results of Operations and Financial Condition). Encompass Health reported financial results for the three and nine months ended September 30, 2026.

Encompass Health Corp 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Encompass Health reported financial results for the three and nine months ended September 30, 2026
  • Press release containing detailed results attached as Exhibit 99.1
  • Same-store metrics include market consolidation and capacity expansions, complicating underlying organic-growth assessment

Item 7.01 · Regulation FD Disclosure

  • Supplemental earnings information scheduled for October 29, 2026, providing investors additional operating and financial detail
  • Key metrics include adjusted EPS, Adjusted EBITDA, leverage ratio, and adjusted free cash flow
  • Adjusted EBITDA and leverage ratio directly support credit-covenant compliance and debt-servicing capacity
  • Covenant breach could trigger immediate debt repayment and restrict borrowing, dividends, payments, and acquisitions
  • Adjusted free cash flow excludes maintenance capital expenditures, noncontrolling-interest distributions, and certain other items, limiting comparability to residual cash flow

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $1,609.5M, up 8.9%, with discharges up 5.7% and revenue per discharge up 4.0%
  • Adjusted EBITDA $346.6M, up 15.5%, outpacing revenue growth and supporting operating leverage
  • Adjusted EPS $1.52, up 23.6%, while operating cash flow increased 33.7% to $362.0M
  • Full-year guidance raised: revenue $6,450M-$6,500M and Adjusted EBITDA $1,395M-$1,415M
  • Growth investments continued with four hospitals, 189 beds, and 85 added beds during the first nine months

Item EX-99.2 · Exhibit EX-99.2

  • Q3 revenue $1,609.5M, up 8.9%, with discharges up 5.7% and revenue per discharge up 4.0%
  • Adjusted EBITDA $346.6M, up 15.5%, expanding operating leverage despite higher bad-debt reserves
  • 2026 guidance raised: revenue $6,450M-$6,500M, adjusted EBITDA $1,395M-$1,415M, adjusted EPS $6.23-$6.37
  • Adjusted free cash flow $634.2M through nine months, supporting $675M-$725M capacity expansion spending
  • Medicare exposure 66.3% of Q3 revenue, while RCD expansion reaches 108 hospitals January 1, 2027

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Encompass Health Corp 8-K filings

Get the next EHC 8-K as it lands

Follow EHC for push alerts, or ask the research agent what this filing means.